The levels of ESR2 RNA were reduced in adrenocortical carcinoma (ACC), ovarian cancer (OV), pheochromocytoma and paraganglioma (PCPG), and testicular germ cell tumors (TGCTs). This evidence concerns the gene ESR2 and ovarian carcinoma.